Development of an enzyme-linked immunosorbent assay for serotyping ureaplasma urealyticum strains using monoclonal

F Echahidi1, G Muyldermans, S Lauwers

  • 1Department of Microbiology, Academisch Ziekenhuis, Vrije Universiteit Brussel, Brussels, Belgium.

Insights

A new enzyme-linked immunosorbent assay (ELISA) using monoclonal antibodies (MAbs) offers a faster and more accurate method for serotyping Ureaplasma urealyticum. This improved diagnostic tool can identify all 14 serotypes from primary cultures.

Area of Science:

  • Microbiology
  • Immunology

Background:

  • Ureaplasma urealyticum presents 14 serotypes, traditionally identified using polyclonal antibodies.
  • Current serotyping methods are laborious, time-consuming, difficult to interpret, and not always suitable for primary isolates.

Purpose of the Study:

  • To develop a novel, efficient enzyme-linked immunosorbent assay (ELISA) for Ureaplasma urealyticum serotyping.
  • To utilize serotype-specific monoclonal antibodies (MAbs) for improved accuracy and ease of use.

Main Methods:

  • Developed an ELISA utilizing 14 serotype-specific MAbs against 14 Ureaplasma urealyticum reference strains.
  • Tested homologous and heterologous reactions, noting three specific cross-reactions.
  • Assessed reproducibility using fractionated and freshly prepared antigens.

Main Results:

  • Strong homologous reactions and negligible heterologous reactions were observed.
  • Identified cross-reactions between MAb 5/serotype 2, MAb 14/serotype 3, and MAb 8/serotype 13.
  • Despite cross-reactions, a combination of MAbs enabled differentiation of all serotypes.
  • ELISA demonstrated good reproducibility, with variations in fresh antigens not affecting overall interpretation.

Conclusions:

  • The developed ELISA method using MAbs is a promising tool for serotyping Ureaplasma urealyticum clinical isolates.
  • This method offers a more efficient and reliable alternative to existing polyclonal antibody-based techniques.